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Introduction
Cancer has been the leading cause of death in Korea 
since 1983, and the annual number of cancer deaths 
has been increasing steadily as Korea becomes an aged 
society. In 2007, the number of cancer deaths was 67,561 
and comprised 27.6% of total deaths (Korean Statistical 
Information Sevice, 2009). Because cancer is the major 
health concern in Korea, an accurate understanding of 
current trends is important for the evaluation of cancer-
control programs. 
Initially, mass screening of cancer was introduced in 
a social insurance program for very limited recipients 
deprived of a financial support from the government. 
In 1988, Pap smear was first introduced in a health 
examination which was serviced to the industrial workers. 
From 1990, cancer screening for five sites of stomach, 
liver, colorectal, breast and cervix was provided to 
applicants among government employees and teachers 
who willingly pay 50% of the fee for test, as part of the 
biennial health examination. However, these programs 
provided benefits to only a small numbers of persons 
so that target population should have been expanded, 
especially for medical aid people because it has been 
known that the lower the social economic status is, the 
1National Cancer Control Institute, National Cancer Center, Goyang, Korea, 2Non-communicable Disease and Health Promotion, 
Western Pacific Regional Office, World Health Organization, Manila, Philippines *For correspondence : hrshin@ncc.re.kr
Abstract
 Cancer has been the most common cause of death in Korea since 1983 and is a major public concern. The 
aim of this study was to analyze the secular trend of cancer mortality in Korea from 1983 to 2007. Mortality and 
population data from 1983 to 2007 were obtained from the Korea Statistical Office. The annual cancer death 
rates for 18 age groups were estimated, and joinpoint regression was applied to detect significant changes in 
cancer mortality. The age-standardized mortality rate for all sites combined increased until the mid-1990s and 
has been decreasing thereafter, this also being the case for cancers of the esophagus, liver, lung and bladder, as 
well as leukemia. With stomach and uterine cancers a constant reduction was evident throughout the period. 
The declines in stomach, liver, and uterine cancer mortality have made major contributions to the recent overall 
favorable trend. Mortality for cancers of the colon and rectum and the prostate increased in the early 2000s and 
then leveled off, whereas female breast cancer mortality has displayed a constant increasing trend. In conclusion, 
overall cancer mortality is decreasing in men and women in Korea, and this trend will probably continue and 
improve further in line with advances in management as well as the expected impact of the national screening 
program for major five cancers over the next decades.
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higher the mortality and morbidity of cancer are. 
In 1996, the Korean government initiated a 
comprehensive ‘10-year Plan for Cancer Control’ 
through 2005. As part of this plan, the National Cancer 
Screening Program (NCSP) administered by the Ministry 
of Health and Welfare, was established to provide 
screening for gastric, breast, and cervix free of charge 
to medical aid recipients (4% of Korean adults) in 1999. 
Target population of the NCSP has been expanded to the 
National Health Insurance (NHI) beneficiaries within 
the lower 20 percent income bracket from 2002, and it 
expanded to lower 50% NHI premium (52% of Korean 
adults) since 2005 (Yoo, 2008). For the lower 50% NHI 
beneficiaries, 80% of the fund was raised from the NHI 
finance, 10% from the central government, and 10% from 
local government for stomach, liver, colorectal and breast 
screening. For cervix screening, 100% was funded from 
the NHI finance. The NCSP is managed and monitored 
by the National Cancer Center cooperating with NHI. 
While the cancer screening programs is introduced and 
expanded during last decade, the impact of the screening 
program in Korea has not been evaluated intensively. 
The goal of cancer screening is the reduction of cancer 
mortality after all, so the assessment of cancer mortality 
is needed since the introduction of cancer screening 
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program in Korea. 
Joinpoint analysis has commonly been used to describe 
changing trends (Wingo et al., 2003; Cayuela et al., 2004; 
Jemal et al., 2005; Stracci et al., 2007; Aleyamma et al., 
2009; Qiu et al., 2009). However, similar analyses of 
cancer trends have not yet been performed in Korea. We 
analyzed the long-term trends in cancer mortality for 12 
cancer sites in men and 14 sites in women in Korea during 
1983-2007. Age-truncated mortality rates for stomach, 
breast, uterine cervix, and colorectal and liver cancer were 
evaluated separately. 
Materials and Methods
Mortality and population data were abstracted by sex, 
year, and age at death during 1983-2007 from the Korea 
National Statistics Office (Korean Statistical Information 
Sevice, 2009). Cause of death was classified according to 
the International Classification of Diseases 10th edition 
(ICD-10) (World Health Organization, 1992). Cancer 
sites for analysis included all cancers combined and the 
most common cancers: esophagus (C15), stomach (C16), 
colon and rectum (C18-C21), liver and intrahepatic bile 
duct (liver) (C22), gallbladder and other parts of billiary 
tract (gallbladder, etc.) (C23-C24), lung and bronchus 
(lung) (C33-C34), breast (C50), uterine cervix (C53-C55), 
ovary (C56), prostate (C61), non-Hodgkin’s lymphoma 
(C82-C85), and leukemia (C90-C95). The cause of death 
between cervix and corpus uteri cancers is considered not 
to reach reasonable accuracy in Korea, so we combined 
cancer of the uterus and uterine cervix for analysis. For 
valid mortality data for cervical cancer, we calculated the 
corrected mortality for cervical cancer using the method 
suggested by Shin et al. (Shin et al., 2008).
Age-standardized rates (ASRs) were calculated 
using the WHO world standard population (Segi, 1960). 
Long-term trends in ASRs of cancer mortality in Korea 
were analyzed using the joinpoint regression model 
(Kim et al., 2000). Joinpoint regression was applied to 
detect significant changes in cancer rates. Changes in the 
annual age-standardized cancer rates were examined by 
calculating the average annual percent change (APC) and 
the corresponding 95% confidence interval. This method 
describes changes in data trends by connecting several 
different line segments on a log scale at ‘joinpoints.’ The 
analysis starts with the minimum number of joinpoints 
(i.e., 0 joinpoint, representing a straight line) and tests 
for model fit with a maximum of four joinpoints. Tests of 
significance use a Monte Carlo permutation method. The 
trends in cancer mortality for men and women who were 
of target age for screening (over 30 years for cervix, over 
40 years for stomach, liver, and breast, and over 50 years 
for colon and rectum), were analyzed separately in order 
to evaluate the national screening program. The analysis 
was performed using Joinpoint software (version 3.3, 
http://srab.cancer.gov/joinpoint) from the Surveillance 
Research Program of the National Cancer Institute in the 
USA (National Cancer Institute, 2009).
We also calculated the contribution of individual 
cancer sites to the change in the overall cancer mortality 
rates based on the method presented in the annual report 
from the American Cancer Society (Jemal et al., 2008). 
The notation is as follows:
  ,
where  represents the mortality rate for site k in year 
t, t0 is the peak year, and t1 is the last year available. We 
used the peak year identified by the joinpoint regression 
model. The peak year was 1995, and last available year 
was 2007.
Results
The crude cancer mortality rate and ASR in males and 
females are presented in Figure 1. The crude rate for all 
cancers combined increased during the study period, but 
age-standardized rates turned to decreasing trends since 
the early 2000s and mid-1990s for men and women, 
respectively.
Tables 1 and 2 list the results of the joinpoint analyses 
by sex and cancer site, applied to mortality rates from 
1983 to 2007. In males, the ASRs for all sites combined 
showed significant increases of 2.8% per year up to 1995, 
leveled off from 1998 to 2002, and decreased significantly 
thereafter by 3.0% per year. Among females, the rates 
increased significantly by 1.5% per year until 1994 and 
then decreased significantly thereafter. 
In males, the leading cause of death was lung cancer 
(ASR of 39.5 per 100,000 in 2007). In males, the ASRs for 
lung cancer increased from 1983 to 1994, leveled off from 
1994 to 2001, and then decreased significantly by 1.8% 
Figure 1. Trend of Crude and Age-Standardized 
Cancer Mortality Rates in Males and Females in 
Korea for 1983-2007
Figure 2. Observed Standardized (Per 100 000 
World Standard) Rates and ‘Best’ Joinpoint Model 
Estimates for All Sites Combined in Korea, 1983-2007
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per year since 2001. In females, lung cancer became the 
second cause of cancer death in 1997, following stomach. 
ASRs of lung cancer increased from 1983 to 1994, leveled 
off from 1995 to 2002, and decreased significantly by 1.7% 
per year since 2002. 
In males, stomach cancer was the most common cancer 
until 1997 and is now the third cause of cancer death, 
after lung and liver. Among females, stomach cancer 
was the most common cancer death. ASRs for stomach 
cancer showed decreasing trends by 3.9 and 5.2% per 
year from 1983 to 1990, leveled off from 1990 to 1993, 
and decreased by 4.6 and 5.5% per year since 1993 in 
males and females, respectively; this decrease was more 
pronounced in women than in men.
Liver cancer was the second cause of cancer deaths 
in males and the third in females. For males, ASRs of 
liver cancer increased by 1.7% per year until 1994, began 
to decrease by 5.0% per year between 1994 and 1998, 
leveled off between 1998 and 2002, and decreased by 
3.4% per year since 2002. For females, ASRs of liver 
Figure 3. Observed Standardized (Per 100 000 World Standard) Rates and ‘Best’ Joinpoint Model Estimates 
for Major Cancer Sites in Korea, 1983-2007
Table 1. Trends in Cancer Mortality Per 100,000 Men by All Cancers Combined and Major Cancers in Korea 
for 1983-2007
Site Line 1 Line 2 Line 3 Line 4
Year APC 95% CI Year APC 95% CI Year APC 95% CI Year APC 95% CI
All sites 1983-1995 2.8* 2.3, 3.3
1995-
1998 -3.0 -9.4, 3.8
1998-
2002 1.0 -2.3, 4.3
2002-
2007 -3.0* -4.3, -1.7
Esophagus 1983-1995 3.7* 2.9, 4.6
1995-
2007 -3.7* -4.3, -3.1
Stomach 1983-1990 -3.9* -5.1, -2.8
1990-
1993 2.3
-6.1, 
11.5
1993-
2007 -4.6 * -5.0, -4.2
Colon & rectum 1983-2002 7.7* 7.1, 8.3
2002-
2007 0.9 -1.2, 3.2
Liver 1983-1994 1.7* 1.4, 2.0
1994-
1998 -5.0* -6.9, -3.1
1998-
2002 -0.7 -2.6, 1.2
2002-
2007 -3.4* -4.2, -2.6
Gallbladder, etc. 1983-1996 14.8*
12.9, 
16.6
1996-
2007 -0.3 -1.3, 0.7
Pancreas 1983-1985 28.1
-6.2, 
74.8
1985-
1994 8.7* 6.4, 11.1
1994-
2001 1.9 -0.5, 4.3
2001-
2007 -1.4 -3.6, 0.6
Lung 1983-1994 9.7* 9.1, 10.2
1994-
1998 0.4 -1.9, 2.8
1998-
2001 3.1 -1.3, 7.6
2001-
2007 -1.8* -2.5, -1.2
Prostate 1983-2002 13.9*
12.7, 
15.0
2002-
2007 1.9 -0.9, 4.9
Bladder 1983-1995 6.7* 4.9, 8.5
1995-
1998 -4.2
-21.4, 
16.9
1998-
2002 10.5* 0.7, 21.2
2002-
2007 -5.8* -9.0, -2.3
Non-Hodgkin’s 
lymphoma
1983-
2007 4.2* 2.7, 5.8
Leukemia 1983-1993 3.8 * 2.3, 5.2
1993-
2007 -1.0* -1.7, -0.2
*Statistically significant compared to zero. APC, annual percent change; CI, confidence interval
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cancer increased by 1.0% per year until 1994, began to 
decrease by 5.2% per year between 1994 and 1999, leveled 
off between 1999 and 2002, and decreased by 3.7% per 
year since 2002.
Colorectal cancer was the fourth leading cause of 
cancer death in males and females. Recent trends (since 
2002 in males, 2004 in females) show a leveling off of 
the mortality rates, following the steady increase observed 
previously. 
The ASR of uterine cancer decreased 2.4% per year 
from 1983 to 1995 and 4.6% per year from 1995 to 2007. 
Along with the significant increase in the incidence of 
prostate and female breast cancer, the mortality rates of 
these cancers have also increased. Mortality from prostate 
cancer increased significantly by 13.9% per year until 
2002, and then leveled off. The mortality rate of breast 
cancer increased by 4.3% per year from 1983 to 1994 and 
by 2.4% per year from 1994 to 2007. Some cancers, such 
as ovarian cancer and non-Hodgkin’s lymphoma, also 
continued to increase during the study period.
Age-standardized mortality rates of esophagus and 
bladder cancer and leukemia increased and then changed 
to decreasing trends in the mid-1990s. Similar patterns 
were observed in males and females. 
The trend for stomach, liver, colon and rectum, 
female breast, uterine, and corrected cervical cancers 
for the screening ages in the national screening program 
are depicted in Figure 3. When truncated rates for the 
screening ages were considered, the trends were similar 
to those observed at all ages, and the degrees were greater 
than those of the all-ages group. 
Table 3 shows the contribution of individual cancer 
sites to the total changes in mortality of all cancers 
combined. Overall cancer mortality rates peaked in 1995 
in men and in 1994 in women. We therefore calculated 
the contribution using the change between 1995 and 2007 
for men and for women. The overall cancer mortality 
rates decreased by 32.9% for men and by 14.6% for 
women. Stomach and liver cancer contributed 78.2% to 
the total decrease in cancer mortality for men. For women, 
stomach, cervical, and liver cancer contributed 85.4% to 
the total decrease in cancer mortality.
Discussion
Understanding cancer trends is important in the 
monitoring of cancer control and to evaluate changes 
in cancer risks, cancer screening modalities, and the 
effectiveness of health care (Wingo et al., 2003). This 
is the first analysis of cancer mortality trends using a 
joinpoint regression analysis of all cancers combined and 
major cancers in Korea during 1983-2007. This analysis 
revealed declining trends of cancer mortality in Korea 
since the mid 1990s. Such declines were also observed in 
Japan, the European Union, and the United States since 
1988 (Levi et al., 2002; Levi et al., 2003; Wingo et al., 
Table 2. Trends in Cancer Mortality Per 100,000 Women by All Cancers Combined and Major Cancers in Korea 
for 1983-2007
Site Line 1 Line 2 Line 3 Line 4
Year APC 95% CI Year APC 95% CI Year APC 95% CI Year APC 95% CI
All sites 1983-1994 1.5* 0.8, 2.2
1994-
2007 -1.0* -1.4, -0.5
Esophagus 1983-1995 -0.8 -2.1, 0.5
1995-
2007 -7.1* -8.3, -5.8
Stomach 1983-1990 -5.2* -6.1, -4.3
1990-
1993 1.2 -5.7, 8.6
1993-
2007 -5.5* -5.8, -5.2
Colon & rectum 1983-1994 9.1* 8.1, 10.2
1994-
2004 4.2* 3.5, 5.0
2004-
2007 -1.6 -4.8, 1.7
Liver 1983-1994 1.0* 0.5, 1.5
1994-
1999 -5.2* -7.2, -3.2
1999-
2002 2.6 -3.8, 9.5
2002-
2007 -3.7* -5.0, -2.3
Gallbladder, etc. 1983-1992 18.7*
15.6, 
21.8
1992-
2001 6.1* 4.6, 7.7
2001-
2007 -1.4  -3.1, 0.3
Pancreas 1983-1994 11.2* 9.8, 12.6
1994-
2007 1.3* 0.7, 1.8
Lung 1983-1994 7.8* 6.7, 8.9
1994-
2002 1.6* 0.2, 2.9
2002-
2007 -1.7 -3.6, 0.2
Breast 1983-1994 4.3* 3.2, 5.5
1994-
2007 2.4* 1.8, 3.0
Uteri 1983-1995 -2.4* -3.2, -1.7
1995-
2007 -4.6* -5.3, -3.9
Cervix (corrected) 1993-2007 -4.5* -5.1, -3.9
Ovary 1983-1993 16.5*
12.8, 
20.4
1993-
2007 3.2* 2.3, 4.2
Bladder 1983-1992 7.9* 3.3, 12.7
1992-
2003 2.8* 0.6, 5.2
2003-
2007 -4.1
-11.2, 
3.5
Non-Hodgkin’s 
lymphoma
1983-
2007 4.6* 3.0, 6.2
Leukemia 1983-1993 2.0* 0.8, 3.3
1993-
2007 -2.0* -2.6, -1.3
* Statistically significant compared with zero. APC, annual percent change; CI, confidence interval
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2003; Qiu et al., 2009). The fall in stomach, liver and 
uterine cancer mortality has contributed to the overall 
recent favorable trend. 
The stomach was the most common cancer site in 
Korea during 1983-2001 and is now the third most 
common site, after lung and colorectal cancers, in mortality 
rates. Northeastern asia, including Korea and Japan, has 
the highest stomach cancer incidence and mortality in 
the world (Ferlay et al., 2004), but this has been reduced 
markedly. The trend in stomach cancer mortality rates has 
been attributed to the effects of substantial improvements 
in food conservation, a more affluent diet with increased 
consumption of fresh fruit and vegetables, and the control 
of Helicobacter pylori infection (Howson et al., 1986; 
Lee et al., 2002; Levi et al., 2004; Crew and Neugut, 
2006; Bertuccio et al., 2009). The 5-year survival rates 
of stomach cancer have increased from 43.0 to 57.0 
(1993-1995 and 2001-2005) in men and from 42.6 to 
55.1 in women (Ministry for Health, Welfare and Family 
Affairs, 2008). This relative improvement in survival is 
likely associated with treatment modification and early 
diagnosis. The national screening program for stomach 
cancer began in 1999 as a part of NCSP. Opportunistic 
screening was also relatively common, and lifetime gastric 
cancer screening rates were 53.5% in the 2006 Korean 
National Cancer Screening Survey (Kwak et al., 2008).
The reduction of liver cancer mortality since 1996 
was interpreted as largely an effect of the decreasing 
prevalence of hepatitis B virus (HBV). HBV infection 
plays the major role in the etiology of liver cancer in 
Korea. About 70% of hepatocellular carcinoma is caused 
by HBV, and approximately 20% by hepatitis C virus 
infection in Korea (Han and Kim, 2007; Kim et al., 
2008). The national HBV vaccination program since 1985 
and the introduction of treatment of chronic hepatitis B 
might also have attributed to reducing the incidence and 
mortality of liver cancer. Over twenty years after the 
initiation of the national HBV vaccination program, the 
number of children testing positive for HBsAg has fallen 
substantially from 7-8%  to 0.6% (Han and Kim, 2007). 
Along with this decrease in the HBsAg carrier state, the 
incidence of liver cancer also decreased by 2.0% annually 
in men and by 1.7% in women from 1999 to 2005 (Jung 
et al., 2009).
Mortality due to uterine cancer has been declining. 
Joinpoint analyses demonstrated that uterine cancer 
mortality rates declined significantly, by 2.4% per year 
from 1983 through 1995 and by 4.6% per year from 1995 
through 2007. The decreasing trend in uterine cancer 
mortality may be due to the introduction of NPCR for 
cervical cancer in 1999.
Lung cancer is the third most common cancer in 
incidence and the most common cancer resulting in death. 
Our results indicate that lung cancer mortality peaked in 
the years 2001-2002 and began to decrease in all ages after 
that time. The smoking rate in Korean adult males (over 
20 years) was 67.6% in 2000; however, the smoking rate 
in females was quite low at 3.0% (Jee, 2003). Although 
the smoking rate in Korean adult males was among the 
highest in the world, the smoking rate has decreased by 
18.8% compared to 1980 (Jee, 2003). The development 
of treatment may also influence the reduction of mortality 
due to lung cancer, especially non-small-cell lung cancer 
(Kim et al., 2009). 
Meanwhile, some cancers such as colon and rectum, 
prostate, and female breast cancers have increased in 
incidence, similar to trends observed in Japan (Qiu et al., 
2009). Colorectal cancer was the second most common 
cancer in 2005, and the incidence increased by 7.4% 
annually in men and by 5.4% in women from 1999 to 2005 
(Jung et al., 2009). The incidence of prostate and female 
breast cancer increased annually from 1999 to 2005 by 
12.9% in women and by 7.1% in men and women (Jung et 
al., 2009). Prostate cancer remains less frequent in Korea 
than in Western populations (Bouchardy et al., 2008), 
although the mortality rate has increased rapidly recent 
years. Breast cancer has been the second most common 
Table 3. Age-standardized (World Population) 
Mortality Rates (per 100,000) from All Cancers 
Combined and Major Cancers in 1995 and 2007
Sites ASM Change   C
    1995   2007   Absolute Relative   (%)
Men
  All sites 191.1 158.2 -32.9 -17.2
  Decreasing
    Stomach 46.1 25.3 -20.7 -45.0 48.9 
    Liver 41.7 29.3 -12.4 -29.8 29.3
    Esophagus 7.9 4.9 -3.0 -38.1 7.1
    Lung 40.2 39.5 -0.7 -1.8 1.7
    Leukemia 3.5 3.2 -0.3 -9.3 0.8
    Bladder 2.8 2.8 0.0 0.0 0.0
    Others 23.5 18.3 -5.2 -22.3 12.3
    Total -42.5 100.0
  Increasing
    Colon & rectum 8.2 14.1 5.9 72.1 60.9
    Prostate 1.9 4.6 2.8 147.8 28.4
    Pancreas 6.7 7.1 0.4 5.7 3.9
    NHL 2.5 2.9 0.4 13.9 3.6
    Gallbladder, etc. 6.0 6.3 0.3 5.2 3.2
    Total 9.7 100.0
Women
  All sites 76.8 65.6 -11.2 -14.6
  Decreasing
    Stomach 18.6 9.3 -9.3 -50.0 55.8
    Cervix (corrected) 5.1 2.8 -2.3 -45.6 13.9
    Liver 10.1 7.5 -2.6 -25.9 15.7
    Leukemia 2.7 2.1 -0.6 -22.1 3.6
    Esophagus 0.8 0.3 -0.5 -59.2 2.7
    Others 9.9 8.6 -1.4 -13.9 8.3
    Total -17.1 100.0
  Increasing
    Colon & rectum 5.3 7.4 2.1 38.5 34.6
    Gallbladder, etc. 3.3 4.4 1.1 33.8 18.5
    Breast 3.8 4.9 1.1 27.6 17.9
    Ovary 1.6 2.3 0.7 43.4 11.6
    Pancreas 3.6 4.2 0.6 16.3 9.9
    NHL 1.1 1.3 0.2 21.1 3.9
    Lung 9.2 9.4 0.1 1.3 2.0
    Bladder 0.5 0.6 0.1 19.1         1.5
    Total 5.9      100.0
ASM, Age standardized mortality; C, Contribution; NHL, Non-
Hodgkin’s lymphoma
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